TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains

Human Molecular Genetics

Volumn 19, Issue 19, 2010, Pages 3759-3770

  Zucchelli, Silvia ^a,b   Codrich, Marta ^a   Marcuzzi, Federica ^a   Pinto, Milena ^a   Vilotti, Sandra ^a   Biagioli, Marta ^a   Ferrer, Isidro ^c   Gustincich, Stefano ^a,b  

^a SISSA   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MUTANT PROTEIN; PARKIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; CONTROLLED STUDY; GENE DUPLICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEWY BODY; MISSENSE MUTATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

ALPHA-SYNUCLEIN; BRAIN; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEWY BODIES; MUTANT PROTEINS; ONCOGENE PROTEINS; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; SUBSTRATE SPECIFICITY; TNF RECEPTOR-ASSOCIATED FACTOR 6; UBIQUITINATION;

EID: 77956526505     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq290     Document Type: Article

References (52)

1. Lesage, S. and Brice, A. (2009) Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet., 18, R48-R59.
2. Schlossmacher, M.G., Frosch, M.P., Gai, W.P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N. et al. (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am. J. Pathol., 160, 1655-1667.
3. Ito, T. (2003) Dorfin localizes to Lewy bodies and ubiquitylates Synphilin-1. J. Biol. Chem., 278, 29106-29114.
4. Liani, E., Eyal, A., Avraham, E., Shemer, R., Szargel, R., Berg, D., Bornemann, A., Riess, O., Ross, C.A., Rott, R. et al. (2004) Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Proc. Natl Acad. Sci. USA, 101, 5500-5505.
5. Shin, Y. (2005) The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J. Biol. Chem., 280, 23727-23734.
6. Chen, Z. and Sun, L. (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell, 33, 275-286.
7. Xu, P., Duong, D.M., Seyfried, N.T., Cheng, D., Xie, Y., Robert, J., Rush, J., Hochstrasser, M., Finley, D. and Peng, J. (2009) Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell, 137, 133-145.
8. Ikeda, H. and Kerppola, T.K. (2008) Lysosomal localization of ubiquitinated Jun requires multiple determinants in a lysine-27-linked polyubiquitin conjugate. Mol. Biol. Cell, 19, 4588-4601.
9. Chastagner, P., Israël, A. and Brou, C. (2006) Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains. EMBO Rep., 7, 1147-1153.
10. Jiang, J., Ballinger, C.A., Wu, Y., Dai, Q., Cyr, D.M., Höhfeld, J. and Patterson, C. (2001) CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J. Biol. Chem., 276, 42938-42944.
11. Al-Hakim, A.K., Zagorska, A., Chapman, L., Deak, M., Peggie, M. and Alessi, D.R. (2008) Control of AMPK-related kinases by USP9X and atypical Lys29/Lys33-linked polyubiquitin chains. Biochem. J., 411, 249.
12. Xu, K., Shimelis, H., Linn, D.E., Jiang, R., Yang, X., Sun, F., Guo, Z., Chen, H., Li, W., Chen, H. et al. (2009) Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell, 15, 270-282.
13. Pype, S., Declercq, W., Ibrahimi, A., Michiels, C., Van Rietschoten, J.G., Dewulf, N., De Boer, M., Vandenabeele, P., Huylebroeck, D. and Remacle, J.E. (2000) TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J. Biol. Chem., 275, 18586-18593.
14. Zucchelli, S., Vilotti, S., Calligaris, R., Lavina, Z.S., Biagioli, M., Foti, R., De Maso, L., Pinto, M., Gorza, M., Speretta, E. et al. (2009) Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations. Cell Death Differ., 16, 428-438.
15. Chen, Z. (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol., 7, 758-765.
16. Wu, H. and Arron, J. (2003) TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays, 25, 1096-1105.
17. Khursigara, G., Orlinick, J.R. and Chao, M.V. (1999) Association of the p75 neurotrophin receptor with TRAF6. J. Biol. Chem., 274, 2597-2600.
18. Geetha, T., Jiang, J. and Wooten, M. (2005) Lysine 63 Polyubiquitination of the nerve growth factor receptor TrkA directs internalization and signaling. Mol. Cell, 20, 301-312.
19. Babu, J., Geetha, T. and Wooten, M. (2005) Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J. Neurochem., 94, 192-203.
20. Lim, K.L., Chew, K.C., Tan, J.M., Wang, C., Chung, K.K., Zhang, Y., Tanaka, Y., Smith, W., Engelender, S., Ross, C.A. et al. (2005) Parkin mediates nonclassical, proteasomal-independent ubiquitination of Synphilin-1: implications for Lewy body formation. J. Neurosci., 25, 2002-2009.
21. Lee, J., Wheeler, T., Li, L. and Chin, L. (2007) Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death. Hum. Mol. Genet., 17, 906-917.
22. Polekhina, G., House, C.M., Traficante, N., Mackay, J.P., Relaix, F., Sassoon, D.A., Parker, M.W. and Bowtell, D.D. (2002) Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-a signaling. Nat. Struct. Biol., 9, 68-75.
23. Humbert, J., Beyer, K., Carrato, C., Mate, J.L., Ferrer, I. and Ariza, A. (2007) Parkin and synphilin-1 isoform expression changes in Lewy body diseases. Neurobiol. Dis., 26, 681-687.
24. Choi, J., Levey, A.I., Weintraub, S.T., Rees, H.D., Gearing, M., Chin, L.S. and Li, L. (2004) Oxidative modifications and down-regulation of 3770 Human Molecular Genetics, 2010, Vol. 19, No. 19 ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem., 279, 13256-13264.
25. Culpan, D., Cram, D., Chalmers, K., Cornish, A., Palmer, L., Palmer, J., Hughes, A., Passmore, P., Craigs, D., Wilcock, G.K. et al. (2009) TNFR-associated factor-2 (TRAF2) in Alzheimer's disease. Neurobiol. Aging, 30, 1052-1060.
26. Sahara, N., Murayama, M., Mizoroki, T., Urushitani, M., Imai, Y., Takahashi, R., Murata, S., Tanaka, K. and Takashima, A. (2005) In vivo evidence of CHIP up-regulation attenuating tau aggregation. J. Neurochem., 94, 1254-1263.
27. Navarro, A., Boveris, A., Bández, M.J., Sanchez-Pinto, M.J., Gómez, C., Muntane, G. and Ferrer, I. (2009) Human brain cortex: mitochondrial oxidative damage and adaptative response in Parkinson disease and dementia with Lewy bodies. Free Radic. Biol. Med., 46, 1574-1580.
28. Wakabayashi, K., Tanji, K., Mori, F. and Takahashi, H. (2007) The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology, 27, 494-506.
29. Beyer, K., Domingo-Sàbat, M. and Ariza, A. (2009) Molecular pathology of lewy body diseases. Int. J. Mol. Sci., 10, 724-745.
30. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. and Goedert, M. (1997) Alpha-synuclein in Lewy bodies. Nature, 388, 839-840.
31. Olzmann, J.A., Li, L., Chudaev, M.V., Chen, J., Perez, F.A., Palmiter, R.D. and Chin, L.S. (2007) Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J. Cell Biol., 178, 1025-1038.
32. Biagioli, M., Pinto, M., Cesselli, D., Zaninello, M., Lazarevic, D., Roncaglia, P., Simone, R., Vlachouli, C., Plessy, C., Bertin, N. et al. (2009) Unexpected expression of alpha-and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc. Natl Acad. Sci. USA, 106, 15454-15459.
33. Macedo, M.G., Anar, B., Bronner, I.F., Cannella, M., Squitieri, F., Bonifati, V., Hoogeveen, A., Heutink, P. and Rizzu, P. (2003) The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. Hum. Mol. Genet., 12, 2807-2816.
34. Olzmann, J.A., Brown, K., Wilkinson, K.D., Rees, H.D., Huai, Q., Ke, H., Levey, A.I., Li, L. and Chin, L.S. (2004) Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J. Biol. Chem., 279, 8506-8515.
35. Shendelman, S., Jonason, A., Martinat, C., Leete, T. and Abeliovich, A. (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol., 2, e362.
36. Herrera, F.E., Zucchelli, S., Jezierska, A., Lavina, Z.S., Gustincich, S. and Carloni, P. (2007) On the oligomeric state of DJ-1 protein and its mutants associated with Parkinson Disease. A combined computational and in vitro study. J. Biol. Chem., 282, 24905-24914.
37. Chin, L.S., Olzmann, J.A. and Li, L. (2010) Parkin-mediated ubiquitin signalling in aggresome formation and autophagy. Biochem. Soc. Trans., 38, 144-149.
38. Olzmann, J.A. and Chin, L.S. (2008) Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway. Autophagy, 4, 85-87.
39. Subauste, C.S., Andrade, R.M. and Wessendarp, M. (2007) CD40-TRAF6 and autophagy-dependent anti-microbial activity in macrophages. Autophagy, 3, 245-248.
40. Auluck, P.K., Chan, H.Y., Trojanowski, J.Q., Lee, V.M. and Bonini, N.M. (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science, 295, 865-868.
41. Qiao, L., Hamamichi, S., Caldwell, K.A., Caldwell, G.A., Yacoubian, T.A., Wilson, S., Xie, Z.L., Speake, L.D., Parks, R., Crabtree, D. et al. (2008) Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol. Brain, 1, 17.
42. Kuwahara, T., Koyama, A., Koyama, S., Yoshina, S., Ren, C.H., Kato, T., Mitani, S. and Iwatsubo, T. (2008) A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. Hum. Mol. Genet., 17, 2997-3009.
43. Nagano, Y., Yamashita, H., Takahashi, T., Kishida, S., Nakamura, T., Iseki, E., Hattori, N., Mizuno, Y., Kikuchi, A. and Matsumoto, M. (2003) Siah-1 facilitates ubiquitination and degradation of Synphilin-1. J. Biol. Chem., 278, 51504-51514.
44. Engelender, S. (2008) Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease. Autophagy, 4, 372-374.
45. Hasegawa, M., Fujiwara, H., Nonaka, T., Wakabayashi, K., Takahashi, H., Lee, V.M., Trojanowski, J.Q., Mann, D. and Iwatsubo, T. (2002) Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J. Biol. Chem., 277, 49071-49076.
46. Tofaris, G.K., Razzaq, A., Ghetti, B., Lilley, K.S. and Spillantini, M.G. (2003) Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem., 278, 44405-44411.
47. Anderson, J.P., Walker, D.E., Goldstein, J.M., de Laat, R., Banducci, K., Caccavello, R.J., Barbour, R., Huang, J., Kling, K., Lee, M. et al. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem., 281, 29739-29752.
48. Rott, R., Szargel, R., Haskin, J., Shani, V., Shainskaya, A., Manov, I., Liani, E., Avraham, E. and Engelender, S. (2008) Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells. J. Biol. Chem., 283, 3316-3328.
49. Engelender, S., Kaminsky, Z., Guo, X., Sharp, A.H., Amaravi, R.K., Kleiderlein, J.J., Margolis, R.L., Troncoso, J.C., Lanahan, A.A., Worley, P.F. et al. (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet., 22, 110-114.
50. Li, W., West, N., Colla, E., Pletnikova, O., Troncoso, J.C., Marsh, L., Dawson, T.M., Jäkälä, P., Hartmann, T., Price, D.L. et al. (2005) Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc. Natl Acad. Sci. USA, 102, 2162-2167.
51. Cuervo, A.M., Stefanis, L., Fredenburg, R., Lansbury, P.T. and Sulzer, D. (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science, 305, 1292-1295.
52. Waldvogel, H.J., Curtis, M.A., Baer, K., Rees, M.I. and Faull, R.L. (2006) Immunohistochemical staining of post-mortem adult human brain sections. Nat. Protoc., 1, 2719-2732.